KAILERA
Live / Applied — First extension granted (statement of use) (as of 06 Feb 2026)
What this means for you
Not registered yet, but its 31 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98676367
- Mark type
- Stylized text
- Filed
- 31 Jul 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Gabriel M. Gillmeyer
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of metabolic and endocrine diseases and disorders; pharmaceutical preparations for the prevention and treatment of medical conditions in the fields of metabolic science and endocrine science
Owner
- KAILERA THERAPEUTICS, INC., WALTHAM, MA, US
- KAILERA THERAPEUTICS, INC., WALTHAM, MA, US
- Hercules CM NewCo, Inc., Dover, DE, US
Prosecution history
- 06 Feb 2026 — SOU EXTENSION 1 GRANTED
- 06 Feb 2026 — SOU EXTENSION 1 FILED
- 06 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Feb 2025 — NON-FINAL ACTION E-MAILED
- 11 Feb 2025 — NON-FINAL ACTION WRITTEN
- 07 Feb 2025 — ASSIGNED TO EXAMINER